» Articles » PMID: 36230812

Lung Subregion Partitioning by Incremental Dose Intervals Improves Omics-Based Prediction for Acute Radiation Pneumonitis in Non-Small-Cell Lung Cancer Patients

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Oct 14
PMID 36230812
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the effectiveness of features obtained from our proposed incremental-dose-interval-based lung subregion segmentation (IDLSS) for predicting grade ≥ 2 acute radiation pneumonitis (ARP) in lung cancer patients upon intensity-modulated radiotherapy (IMRT). (1) Materials and Methods: A total of 126 non-small-cell lung cancer patients treated with IMRT were retrospectively analyzed. Five lung subregions (SRs) were generated by the intersection of the whole lung (WL) and five sub-regions receiving incremental dose intervals. A total of 4610 radiomics features (RF) from pre-treatment planning computed tomographic (CT) and 213 dosiomics features (DF) were extracted. Six feature groups, including WL-RF, WL-DF, SR-RF, SR-DF, and the combined feature sets of WL-RDF and SR-RDF, were generated. Features were selected by using a variance threshold, followed by a Student t-test. Pearson’s correlation test was applied to remove redundant features. Subsequently, Ridge regression was adopted to develop six models for ARP using the six feature groups. Thirty iterations of resampling were implemented to assess overall model performance by using the area under the Receiver-Operating-Characteristic curve (AUC), accuracy, precision, recall, and F1-score. (2) Results: The SR-RDF model achieved the best classification performance and provided significantly better predictability than the WL-RDF model in training cohort (Average AUC: 0.98 ± 0.01 vs. 0.90 ± 0.02, p < 0.001) and testing cohort (Average AUC: 0.88 ± 0.05 vs. 0.80 ± 0.04, p < 0.001). Similarly, predictability of the SR-DF model was significantly stronger than that of the WL-DF model in training cohort (Average AUC: 0.88 ± 0.03 vs. 0.70 ± 0.030, p < 0.001) and in testing cohort (Average AUC: 0.74 ± 0.08 vs. 0.65 ± 0.06, p < 0.001). By contrast, the SR-RF model significantly outperformed the WL-RF model only in the training set (Average AUC: 0.93 ± 0.02 vs. 0.85 ± 0.03, p < 0.001), but not in the testing set (Average AUC: 0.79 ± 0.05 vs. 0.77 ± 0.07, p = 0.13). (3) Conclusions: Our results demonstrated that the IDLSS method improved model performance for classifying ARP with grade ≥ 2 when using dosiomics or combined radiomics-dosiomics features.

Citing Articles

Radiation-induced lung injury: from mechanism to prognosis and drug therapy.

Wang S, Xu D, Xiao L, Liu B, Yuan X Radiat Oncol. 2025; 20(1):39.

PMID: 40082925 PMC: 11907960. DOI: 10.1186/s13014-025-02617-8.


Development and validation of a lung biological equivalent dose-based multiregional radiomic model for predicting symptomatic radiation pneumonitis after SBRT in lung cancer patients.

Jiao Y, Feng A, Li S, Ren Y, Gao H, Chen D Front Oncol. 2024; 14:1489217.

PMID: 39711952 PMC: 11659668. DOI: 10.3389/fonc.2024.1489217.


Multi-omics and Multi-VOIs to predict esophageal fistula in esophageal cancer patients treated with radiotherapy.

Guo W, Li B, Xu W, Cheng C, Qiu C, Sam S J Cancer Res Clin Oncol. 2024; 150(2):39.

PMID: 38280037 PMC: 10821966. DOI: 10.1007/s00432-023-05520-5.


A multiomics approach-based prediction of radiation pneumonia in lung cancer patients: impact on survival outcome.

Niu L, Chu X, Yang X, Zhao H, Chen L, Deng F J Cancer Res Clin Oncol. 2023; 149(11):8923-8934.

PMID: 37154927 DOI: 10.1007/s00432-023-04827-7.


Multimodal Data Integration to Predict Severe Acute Oral Mucositis of Nasopharyngeal Carcinoma Patients Following Radiation Therapy.

Dong Y, Zhang J, Lam S, Zhang X, Liu A, Teng X Cancers (Basel). 2023; 15(7).

PMID: 37046693 PMC: 10093711. DOI: 10.3390/cancers15072032.


References
1.
Luna J, Chao H, Diffenderfer E, Valdes G, Chinniah C, Ma G . Predicting radiation pneumonitis in locally advanced stage II-III non-small cell lung cancer using machine learning. Radiother Oncol. 2019; 133:106-112. DOI: 10.1016/j.radonc.2019.01.003. View

2.
Cai J, Read P, Larner J, Jones D, Benedict S, Sheng K . Reproducibility of interfraction lung motion probability distribution function using dynamic MRI: statistical analysis. Int J Radiat Oncol Biol Phys. 2008; 72(4):1228-35. DOI: 10.1016/j.ijrobp.2008.07.028. View

3.
Seppenwoolde Y, Muller S, Theuws J, Baas P, Belderbos J, Boersma L . Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2000; 47(3):681-90. DOI: 10.1016/s0360-3016(00)00454-5. View

4.
Pan W, Bian C, Zou G, Zhang C, Hai P, Zhao R . Combing NLR, V20 and mean lung dose to predict radiation induced lung injury in patients with lung cancer treated with intensity modulated radiation therapy and chemotherapy. Oncotarget. 2017; 8(46):81387-81393. PMC: 5655293. DOI: 10.18632/oncotarget.19032. View

5.
Ferlay J, Colombet M, Soerjomataram I, Parkin D, Pineros M, Znaor A . Cancer statistics for the year 2020: An overview. Int J Cancer. 2021; . DOI: 10.1002/ijc.33588. View